Cagrilintide is a synthetic 39-amino acid acylated peptide analog classified as a dual amylin and calcitonin receptor agonist (DACRA), available as a lyophilized powder for laboratory research
Hence, a peptide was designed by substituting the negatively charged residues D42, D48, D49, E51, E56, and D57 within the p53 TAD PEP with alanine to increase its binding affinity to FOXO4 FHD and enhance membrane penetration
PubMed indexing shows approximately 100+ publications for BPC-157 (predominantly from one group) and 150+ publications for GHK-Cu (from multiple independent laboratories across the United States, South Korea, Iran, and Europe)
The following resources are now available to read on WADAs website: The full 2024 Prohibited List The WADA 2024 Summary of Major Modifications and Explanatory Notes The 2024 Monitoring Programme which includes substances not currently on the Prohibited List, but are being monitored by WADA for potential patterns of misuse in sport
Wolverine Peptide Characteristics (BPC-157 + TB-500) Wolverine is a research-only peptide blend combining BPC-157 and TB-500, formulated for convenience and compatibility in studies focused on tissue regeneration, inflammation modulation, and post-injury recovery
Being antimicrobial and anti-fungal, this powerful additive helps combat infections, boost your immune system all while promoting healing
